Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study.
SARS-CoV-2
bacterial pulmonary co-infection
influenza
intensive care
outcome
ventilator-associated pneumonia
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
20 Oct 2022
20 Oct 2022
Historique:
received:
27
09
2022
revised:
16
10
2022
accepted:
17
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Few data are available on the impact of bacterial pulmonary co-infection (RespCoBact) during COVID-19 (CovRespCoBact). The aim of this study was to compare the prognosis of patients admitted to an ICU for This was a multicentre ( Of the 1349 patients included, 157 were admitted for SARS-CoV-2 pneumonia was associated with an increased risk of mortality compared with
Sections du résumé
BACKGROUND
BACKGROUND
Few data are available on the impact of bacterial pulmonary co-infection (RespCoBact) during COVID-19 (CovRespCoBact). The aim of this study was to compare the prognosis of patients admitted to an ICU for
METHODS
METHODS
This was a multicentre (
RESULTS
RESULTS
Of the 1349 patients included, 157 were admitted for
CONCLUSIONS
CONCLUSIONS
SARS-CoV-2 pneumonia was associated with an increased risk of mortality compared with
Identifiants
pubmed: 36289906
pii: biomedicines10102646
doi: 10.3390/biomedicines10102646
pmc: PMC9599916
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Pfizer (France)
ID : 64764929
Organisme : Pfizer (France)
ID : 64764929
Références
Reanimation. 2011;20(3):162-168
pubmed: 32288724
Ann Intensive Care. 2020 Sep 7;10(1):119
pubmed: 32894364
Antibiotics (Basel). 2020 Jul 05;9(7):
pubmed: 32635601
Infect Dis (Lond). 2021 Feb;53(2):111-121
pubmed: 33170050
Antibiotics (Basel). 2022 Jul 04;11(7):
pubmed: 35884147
Intensive Care Med. 2020 May;46(5):888-906
pubmed: 32157357
Crit Care Explor. 2021 Jan 22;3(1):e0329
pubmed: 33521646
Respir Care. 2015 Oct;60(10):1383-9
pubmed: 26060320
Crit Care Med. 2005 Jul;33(7):1538-48
pubmed: 16003060
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Am J Respir Crit Care Med. 2021 Sep 1;204(5):546-556
pubmed: 34038699
Crit Care. 2022 Jun 2;26(1):158
pubmed: 35655224
J Med Microbiol. 2021 Apr;70(4):
pubmed: 33861190
Ann Intensive Care. 2021 Jan 29;11(1):20
pubmed: 33512602
Infection. 2022 Feb;50(1):139-148
pubmed: 34260055
Ann Am Thorac Soc. 2021 Apr;18(4):632-640
pubmed: 33183067
BMC Infect Dis. 2018 Dec 7;18(1):637
pubmed: 30526505
Immunity. 2020 Sep 15;53(3):685-696.e3
pubmed: 32783921
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Chest. 2012 Sep;142(3):583-592
pubmed: 22948576
Intensive Care Med. 2018 Dec;44(12):2216-2218
pubmed: 29797028
Trends Microbiol. 2021 Oct;29(10):930-941
pubmed: 33934980
Crit Care. 2022 Aug 3;26(1):236
pubmed: 35922860
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699
pubmed: 32667207
Biomedicines. 2022 Aug 11;10(8):
pubmed: 36009500
Lancet Microbe. 2021 Aug;2(8):e354-e365
pubmed: 34100002
Infection. 2021 Jun;49(3):559-562
pubmed: 33393065
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
Crit Care Med. 2012 May;40(5):1487-98
pubmed: 22511131
Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821
pubmed: 32584597
PLoS One. 2021 May 6;16(5):e0251170
pubmed: 33956882